ASH 2019, Orlando – More than 25.000 attendees from more than 115 countries gather together in the 61st American Society of Hematology (ASH) Annual Congress. This is the largest world congress of hematology and will be held from today to 10 December 2019 in Orlando, Florida, USA.
There will be a number of myeloma updates. CAR-T, novel immunotherapies, drug combinations or the role of Minimal Residual Disease (MRD) will be some of the topics. Dr Katja Weisel, University Medical Center Hamburg-Eppendorf in Germany, spent some time with MPE to explain us the expected myeloma updates in the upcoming days.
